Rentokil Initial Stock Surges: Analyst Upgrades, Growth, and Risks
Rentokil Initial’s RNTOK stock climbs above its 200‑day MA, amid analyst upgrades and a growing North American presence, but investors must weigh regulatory, tech‑disruption, and ESG risks to gauge true upside.
4 minutes to read









